Keyword: Synergy Pharmaceuticals
Bausch Health is working to pay down debt and focusing on "organic growth," but one analyst says the company hasn't changed much from the old Valeant.
Bausch hopes it can turn around Synergy's struggling constipation drug Trulance to complement its own Xifaxan.
With its Trulance launch on the skids, Synergy is running out of cash and needs to win new debt terms to avoid bankruptcy.
Shire just nabbed FDA panel backing for prucalopride, aiming to challenge Allergan and Synergy in the chronic constipation market.
Never underestimate the power of positivity, which triumphed in the latest round of voting in FiercePharma’s drug-naming shootout.
Synergy has a new indication for GI med Trulance, and to celebrate, it’s bringing its contract sales force on full time.
A New Year often rings in higher drug prices, and many top companies marked the occasion just that way this year.
Buried in OTC remedies like laxatives, fiber and probiotics? That's the question in Allergan and Ironwood's latest Linzess ads.
Just as Synergy’s Trulance was settling into challenge mode, Express Scripts has dealt it a serious blow.
Several exclusions in Express Scripts' new formulary, or a lack thereof in some fields, highlight trends in the drug business.